Employees
560
People in R&D
22
Revenues 2019
€ 100,7mn
Pharma Clients
80
Doppel
Established in 1994, Doppel is today recognized as one of Europe’s leading experts in contract R&D and manufacturing. It has start-of-the-art facilities and highest scientific capabilities to service its international pharmaceutical and nutritional clients.
News & Highlights
Welcome Sotax CE7
We are very proud to welcome Sotax CE7 Smart flow-through dissolution testing system a.k.a #USP IV apparatus or EP Flow-through cell in our labs! Doppel Farmaceutici R&D Unit consolidates his capability in [...]
Doppel Farmaceutici annuncia l’acquisizione di Dietopack.
E’ con orgoglio ed immenso piacere che Doppel Farmaceutici annuncia l’acquisizione del 90% di Dietopack, azienda emiliana tra le principali in Italia che sviluppa, produce e confeziona integratori, alimenti [...]
Internationalization of a European CDMO
Doppel is a leading Italian, finished dose contract development and manufacturing organization (CDMO) with aggressive plans for expanding its presence in international markets. Backed by a private equity firm with [...]
Environmental KPI
OVERALL SCORE
ENVIRONMENT
LABOR & HUMAN RIGHTS
ETHICS
SUSTAINABLE PROCUREMENT
Corporate history highlights
The company is committed to applying its innovative technologies, deep knowledge and broad experience to develop products of the highest quality for its customers worldwide.
Doppel has a strong track record in building and forging close partnerships with its customers. The company works very closely with its partners to provide high quality services tailored to the specific needs of each individual customer at all stages from formulation, development and manufacturing all the way to marketing and post-marketing controls.
In particular, Doppel provides a specialist consultative service to customers prior to each project in order to determine together the most effective and bespoke solution for the product.